Merck initiates cash tender offer to buy Imago BioSciences
The latest move follows a definitive agreement signed by the companies on 21 November this year. Merck stated that the tender offer will expire on 10 January next
Diamyd Medical has announced the receipt of fast track designation from the US Food and Drug Administration (FDA) for type 1 diabetes treatment, Diamyd.
Darovasertib is a potential first-in-class protein kinase C (PKC) inhibitor, and crizotinib is an investigational cMET inhibitor. The designation will allow the darovasertib / crizotinib development programme to
The multi-target, multi-year partnership will combine the clinical and commercial knowledge of Rallybio in rare diseases with AbCellera’s antibody discovery engine for identifying optimal clinical candidates and providing